Notice2024-03712
Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc.
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 23, 2024
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Siemens Healthcare Diagnostics Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 37 (Friday, February 23, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 37 (Friday, February 23, 2024)]
[Notices]
[Pages 13744-13745]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-03712]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1322]
Bulk Manufacturer of Controlled Substances Application: Siemens
Healthcare Diagnostics Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Siemens Healthcare Diagnostics Inc. has applied to be
registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to Supplementary Information listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 23, 2024. Such persons may also file a written request for a
hearing on the application on or before April 23, 2024.
ADDRESSES: The Drug Enforcement Administration (DEA) requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on January 10, 2024, Siemens Healthcare Diagnostics
Inc., 100 GBC Drive, Mailstop 108, Newark, Delaware 19702-2461 applied
to be registered as a bulk manufacturer of the following basic
class(es) of controlled substance(s):
[[Page 13745]]
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Ecgonine................................ 9180 II
------------------------------------------------------------------------
The company plans to produce the listed controlled substance in
bulk to be used in the manufacture of the DEA exempt products. No other
activities for this drug code is authorized for this registration.
Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-03712 Filed 2-22-24; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on February 23, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.